| Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 RP Dellinger, MM Levy, A Rhodes, D Annane, H Gerlach, SM Opal, ... Critical care medicine 41 (2), 580-637, 2013 | 22134* | 2013 |
| Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock RP Dellinger, JM Carlet, H Masur, H Gerlach, T Calandra, J Cohen, ... Critical care medicine 32 (3), 858-873, 2004 | 6335 | 2004 |
| Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national … B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ... Clinical infectious diseases 46 (12), 1813-1821, 2008 | 5609 | 2008 |
| Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America PG Pappas, CA Kauffman, D Andes, DK Benjamin Jr, TF Calandra, ... Clinical infectious diseases: an official publication of the Infectious …, 2009 | 3885 | 2009 |
| Macrophage migration inhibitory factor: a regulator of innate immunity T Calandra, T Roger Nature reviews immunology 3 (10), 791-800, 2003 | 2096 | 2003 |
| 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer WT Hughes, D Armstrong, GP Bodey, EJ Bow, AE Brown, T Calandra, ... Clinical infectious diseases 34 (6), 730-751, 2002 | 1993 | 2002 |
| Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group … JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ... Clinical Infectious Diseases 71 (6), 1367-1376, 2020 | 1891 | 2020 |
| MIF as a glucocorticoid-induced modulator of cytokine production T Calandra, J Bernhagen, CN Metz, LA Spiegel, M Bacher, T Donnelly, ... Nature 377 (6544), 68-71, 1995 | 1487 | 1995 |
| MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia J Bernhagen, T Calandra, RA Mitchell, SB Martin, KJ Tracey, W Voelter, ... Nature 365 (6448), 756-759, 1993 | 1307 | 1993 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non‐neutropenic adult patients OA Cornely, M Bassetti, T Calandra, J Garbino, BJ Kullberg, O Lortholary, ... Clinical Microbiology and Infection 18, 19-37, 2012 | 1303 | 2012 |
| The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. T Calandra, J Bernhagen, RA Mitchell, R Bucala The Journal of experimental medicine 179 (6), 1895-1902, 1994 | 1286 | 1994 |
| Sepsis: a roadmap for future research J Cohen, JL Vincent, NKJ Adhikari, FR Machado, DC Angus, T Calandra, ... The Lancet infectious diseases 15 (5), 581-614, 2015 | 1135 | 2015 |
| Protection from septic shock by neutralization of macrophage migration inhibitory factor T Calandra, B Echtenacher, DL Roy, J Pugin, CN Metz, L Hültner, ... Nature medicine 6 (2), 164-170, 2000 | 1031 | 2000 |
| Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes A Pascual, T Calandra, S Bolay, T Buclin, J Bille, O Marchetti Clinical infectious diseases 46 (2), 201-211, 2008 | 1024 | 2008 |
| An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. M Bacher, CN Metz, T Calandra, K Mayer, J Chesney, M Lohoff, D Gemsa, ... Proceedings of the National Academy of Sciences 93 (15), 7849-7854, 1996 | 897 | 1996 |
| The international sepsis forum consensus conference on definitions of infection in the intensive care unit T Calandra, J Cohen Critical care medicine 33 (7), 1538-1548, 2005 | 870 | 2005 |
| MIF regulates innate immune responses through modulation of Toll-like receptor 4 T Roger, J David, MP Glauser, T Calandra Nature 414 (6866), 920-924, 2001 | 768 | 2001 |
| Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 R Kleemann, A Hausser, G Geiger, R Mischke, A Burger-Kentischer, ... Nature 408 (6809), 211-216, 2000 | 751 | 2000 |
| European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study … B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ... Clin Infect Dis 46 (12), 1813-1821, 2008 | 725 | 2008 |
| Prognostic values of tumor necrosis factor/cachectin, interleukin-l, interferon-α, and interferon-γ in the serum of patients with septic shock T Calandra, JD Baumgartner, GE Grau, MM Wu, PH Lambert, ... Journal of Infectious Diseases 161 (5), 982-987, 1990 | 698 | 1990 |
